Pharmacy

HomeAlpha IndexCategories

Bookmark and Share

Allergy

Anti Bacterial

Anti Convulsants

Anti Depressants

Anti Fungal

Anti Narcoleptic

Anti Viral

Antibiotics

Arthritis

Asthma

Birth Control

Blood Pressure

Cancer

Cardiovascular

Cholesterol

Diabetes

Diuretics

Eye Drops

Gastrointestinal

Hair Care

Herbal Supplements

Men's Health

Migraines

Muscle Relaxers

Nausea & Vomiting

Other

Pain Medicine

Pet Remedies

Respiratory

Skin Care

Stop Smoking

Thyroid

Weight Loss

Women's Health

Home

Alphabetical Index

Categories

DUOVIR N GENERIC LAMIVUDINE

Pharmacy

Home » Prescription Drugs 6 » DUOVIR N GENERIC LAMIVUDINE

Antiretroviral. For treatment of HIV infection in combination of Lamivudine Zidovudine and Nevirapine

Buy DUOVIR N GENERIC LAMIVUDINE and other Prescription Drugs 6 products online at Medstore.

Buy Online at Medstore - Click Here!

About DUOVIR N GENERIC LAMIVUDINE:

Product Type: Prescription Drugs 6

DUOVIR N ( GENERIC LAMIVUDINE/ZIDOVUDINE/NEVIRAPINE )

DUOVIR N (GENERIC LAMIVUDINE/ZIDOVUDINE/NEVIRAPINE)

GENERIC LAMIVUDINE/ZIDOVUDINE/NEVIRAPINE

150/300/200mg 30 Tablet 3 x 30 Tablet 2 x 30 Tablet GENERIC LAMIVUDINE/ZIDOVUDINE/NEVIRAPINE DUOVIR N

View more Prescription Drugs 6

Previous Product  Next Product

Pharmacy: Dozens of patents for name-brand drugs are due to expire within the next 14 months, and generic drugs will replace some of the most popular and widely advertised drugs used today. For millions of people worldwide, this means switching from familiar brands like Lipitor to generic equivalents. How will this affect drug companies, and what will be the impact on people who depend on expensive prescription medication? Here, a brief guide: Which drugs are scheduled to go generic? Some real blockbusters. "In the next two years, six of the 10 top-selling drugs will lose their patents," says Chris Woolston in the Los Angeles Times. Lipitor, the world's best-selling drug, which is used to lower cholesterol, will be available as a generic in November of this year. Another best-seller, the blood thinner Plavix, will lose its patent in May 2012. Other well-known drugs with expiring patents include the arthritis treatment Enbrel, the anti-psychotic Zyprexa, as well as drugs for bipolar disorder, HIV, high cholesterol, and other conditions.